-
1
-
-
34247646400
-
The incidence and impact of thrombocytopenia in myelodysplastic syndromes
-
Kantarjian H., Giles F., List A., Lyons R., Sekeres M., Pierce S., et al. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer 2007, 109:1705-1714.
-
(2007)
Cancer
, vol.109
, pp. 1705-1714
-
-
Kantarjian, H.1
Giles, F.2
List, A.3
Lyons, R.4
Sekeres, M.5
Pierce, S.6
-
2
-
-
36348930556
-
Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia
-
Atallah E., Cortes J., O'Brien S., Pierce S., Rios M.B., Estey E., et al. Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia. Blood 2007, 110:3547-3551.
-
(2007)
Blood
, vol.110
, pp. 3547-3551
-
-
Atallah, E.1
Cortes, J.2
O'Brien, S.3
Pierce, S.4
Rios, M.B.5
Estey, E.6
-
3
-
-
34249719511
-
Phase I clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
-
Jenkins J.M., Williams D., Deng Y., Uhl J., Kitchen V., Collins D., et al. Phase I clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 2007, 109:4739-4741.
-
(2007)
Blood
, vol.109
, pp. 4739-4741
-
-
Jenkins, J.M.1
Williams, D.2
Deng, Y.3
Uhl, J.4
Kitchen, V.5
Collins, D.6
-
4
-
-
36549001698
-
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
-
Bussel J., Cheng G., Saleh M.N., Psaila B., Kovaleva K., Meddeb B., et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007, 357:2237-2247.
-
(2007)
N Engl J Med
, vol.357
, pp. 2237-2247
-
-
Bussel, J.1
Cheng, G.2
Saleh, M.N.3
Psaila, B.4
Kovaleva, K.5
Meddeb, B.6
-
5
-
-
60249099882
-
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial
-
Bussel J., Provan D., Shamsi T., Cheng G., Psaila B., Kovaleva L., et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial. The Lancet 2009, 373:641-648.
-
(2009)
The Lancet
, vol.373
, pp. 641-648
-
-
Bussel, J.1
Provan, D.2
Shamsi, T.3
Cheng, G.4
Psaila, B.5
Kovaleva, L.6
-
6
-
-
36549047972
-
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C
-
McHutchison J.G., Dusheiko G., Shiffman M.L., Rodriguez-Torres M., Sigal S., Bourlier M., et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med 2007, 357:2227-2236.
-
(2007)
N Engl J Med
, vol.357
, pp. 2227-2236
-
-
McHutchison, J.G.1
Dusheiko, G.2
Shiffman, M.L.3
Rodriguez-Torres, M.4
Sigal, S.5
Bourlier, M.6
-
7
-
-
62549113252
-
The discovery of eltrombopag, an orally bioavailable TpoR agonist
-
Academic Press, Burlington, MA, B.W. Metcalf, S. Dillon (Eds.)
-
Duffy K.J., Erickson-Miller C.L. The discovery of eltrombopag, an orally bioavailable TpoR agonist. Target validation in drug discovery 2007, 241-254. Academic Press, Burlington, MA. 1st ed. B.W. Metcalf, S. Dillon (Eds.).
-
(2007)
Target validation in drug discovery
, pp. 241-254
-
-
Duffy, K.J.1
Erickson-Miller, C.L.2
-
8
-
-
62549153611
-
Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist
-
Erickson-Miller C.L., Delorme E., Tian S.-S., Hopson C.B., Landis A., Valoret E.I., et al. Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist. Stem Cells 2009, 27:424-430.
-
(2009)
Stem Cells
, vol.27
, pp. 424-430
-
-
Erickson-Miller, C.L.1
Delorme, E.2
Tian, S.-S.3
Hopson, C.B.4
Landis, A.5
Valoret, E.I.6
-
9
-
-
0027257805
-
Expression of the c-mpl proto-oncogene in human hematologic malignancies
-
Vignon I., Dreyfus F., Melle J., Viguie F., Ribrag V., Cocault L., et al. Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood 1993, 82:877-883.
-
(1993)
Blood
, vol.82
, pp. 877-883
-
-
Vignon, I.1
Dreyfus, F.2
Melle, J.3
Viguie, F.4
Ribrag, V.5
Cocault, L.6
-
10
-
-
0343293998
-
Analysis of thrombopoietin receptor (c-mpl) mRNA expression in de novo acute myeloid leukemia
-
Schroder J.K., Kolkenbrock S., Tins J., Kasimir-Bauer S., Seeber S., Schutte J. Analysis of thrombopoietin receptor (c-mpl) mRNA expression in de novo acute myeloid leukemia. Leukemia Research 2000, 24:401-409.
-
(2000)
Leukemia Research
, vol.24
, pp. 401-409
-
-
Schroder, J.K.1
Kolkenbrock, S.2
Tins, J.3
Kasimir-Bauer, S.4
Seeber, S.5
Schutte, J.6
-
11
-
-
0034092780
-
Effect of thrombopoietin on acute myelogenous leukemia blasts
-
Tokunaga Y., Miyamoto T., Gondo H., Okamura T., Niho Y. Effect of thrombopoietin on acute myelogenous leukemia blasts. Leuk Lymphoma 2000, 37:27-37.
-
(2000)
Leuk Lymphoma
, vol.37
, pp. 27-37
-
-
Tokunaga, Y.1
Miyamoto, T.2
Gondo, H.3
Okamura, T.4
Niho, Y.5
-
12
-
-
0029019022
-
Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin
-
Matsumura I., Kanakura Y., Kato T., Ikeda H., Ishikawa J., Horikawa Y., et al. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 1995, 86:703-709.
-
(1995)
Blood
, vol.86
, pp. 703-709
-
-
Matsumura, I.1
Kanakura, Y.2
Kato, T.3
Ikeda, H.4
Ishikawa, J.5
Horikawa, Y.6
-
13
-
-
0029831997
-
Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia
-
Motoji T., Takanashi M., Motomura S., Yan-Hua W., Shiozaki H., Aoyama M., et al. Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia. Brit J Haematol 1996, 94:513-516.
-
(1996)
Brit J Haematol
, vol.94
, pp. 513-516
-
-
Motoji, T.1
Takanashi, M.2
Motomura, S.3
Yan-Hua, W.4
Shiozaki, H.5
Aoyama, M.6
-
14
-
-
0031887404
-
Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia
-
Takeshita A., Shinjo K., Izumi M., Ling P., Nakamura S., Naito K., et al. Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia. Brit J Haematol 1998, 100:283-290.
-
(1998)
Brit J Haematol
, vol.100
, pp. 283-290
-
-
Takeshita, A.1
Shinjo, K.2
Izumi, M.3
Ling, P.4
Nakamura, S.5
Naito, K.6
-
15
-
-
0030979448
-
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy
-
Wetzler M., Baer M.R., Bernstein S.H., Blumenson L., Stewart C., Barcos M., et al. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy. J Clin Oncol 1997, 15:2262-2268.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2262-2268
-
-
Wetzler, M.1
Baer, M.R.2
Bernstein, S.H.3
Blumenson, L.4
Stewart, C.5
Barcos, M.6
-
16
-
-
0030905415
-
Megakaryocyte growth and development factor (MGDF)-induced acute leukemia cell proliferation and clonal growth is associated with functional c-mpl
-
Piacibello W., Sanavio F., Brizzi M.F., Garetto L., Severino A., Aronica M.G., et al. Megakaryocyte growth and development factor (MGDF)-induced acute leukemia cell proliferation and clonal growth is associated with functional c-mpl. Leukemia 1997, 11:531-540.
-
(1997)
Leukemia
, vol.11
, pp. 531-540
-
-
Piacibello, W.1
Sanavio, F.2
Brizzi, M.F.3
Garetto, L.4
Severino, A.5
Aronica, M.G.6
-
17
-
-
8544221847
-
Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia
-
Hirai H., Shimazaki C., Yamagata N., Goto H., Inaba T., Kikuta T., et al. Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia. Eur J Haematol 1997, 59:38-46.
-
(1997)
Eur J Haematol
, vol.59
, pp. 38-46
-
-
Hirai, H.1
Shimazaki, C.2
Yamagata, N.3
Goto, H.4
Inaba, T.5
Kikuta, T.6
-
18
-
-
9844268495
-
The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia
-
Adams J.A., Liu Yin J.A., Brereton M.L., Briggs M., Burgess R., Hyde K. The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia. Br J Haematol 1997, 99:139-146.
-
(1997)
Br J Haematol
, vol.99
, pp. 139-146
-
-
Adams, J.A.1
Liu Yin, J.A.2
Brereton, M.L.3
Briggs, M.4
Burgess, R.5
Hyde, K.6
-
19
-
-
0032103562
-
Proliferative reaction of myelogenous leukemia cells with cytokines G-CSF, GM-CSF, M-CSF, SCF and TPO
-
Murayama T., Imoto S., Natazuka T., Chihara K., Matsui T. Proliferative reaction of myelogenous leukemia cells with cytokines G-CSF, GM-CSF, M-CSF, SCF and TPO. Leukemia Research 1998, 22:557-560.
-
(1998)
Leukemia Research
, vol.22
, pp. 557-560
-
-
Murayama, T.1
Imoto, S.2
Natazuka, T.3
Chihara, K.4
Matsui, T.5
-
20
-
-
0029932842
-
Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells
-
Quentmeier H., Zaborski M., Graf G., Ludwig W.D., Drexler H.G. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia 1996, 10:297-310.
-
(1996)
Leukemia
, vol.10
, pp. 297-310
-
-
Quentmeier, H.1
Zaborski, M.2
Graf, G.3
Ludwig, W.D.4
Drexler, H.G.5
-
21
-
-
0035145597
-
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells
-
Petrucci M.T., Ricciardi M.R., Gregorj C., Ariola C., Mazzola F., Fogli M., et al. Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells. Leuk Lymphoma 2000, 40:179-190.
-
(2000)
Leuk Lymphoma
, vol.40
, pp. 179-190
-
-
Petrucci, M.T.1
Ricciardi, M.R.2
Gregorj, C.3
Ariola, C.4
Mazzola, F.5
Fogli, M.6
-
22
-
-
0019952276
-
Proposals for the classification of the myelodysplastic syndromes
-
Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Brit J Haematol 1982, 51:189-199.
-
(1982)
Brit J Haematol
, vol.51
, pp. 189-199
-
-
Bennett, J.M.1
Catovsky, D.2
Daniel, M.T.3
Flandrin, G.4
Galton, D.A.G.5
Gralnick, H.R.6
-
23
-
-
57649184088
-
Control of autophagy by oncogenes and tumor suppressor genes
-
Maiuri M.C., Tasdemir E., Criollo A., Morselli E., Vicencio J.M., Cornuccio R., et al. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 2009, 16:87-93.
-
(2009)
Cell Death Differ
, vol.16
, pp. 87-93
-
-
Maiuri, M.C.1
Tasdemir, E.2
Criollo, A.3
Morselli, E.4
Vicencio, J.M.5
Cornuccio, R.6
-
24
-
-
36248962144
-
A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion
-
Overholtzer M., Mailleux A., Mouneimne G., Normand G., Schnitt S.J., King R.W., et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 2007, 131:966-979.
-
(2007)
Cell
, vol.131
, pp. 966-979
-
-
Overholtzer, M.1
Mailleux, A.2
Mouneimne, G.3
Normand, G.4
Schnitt, S.J.5
King, R.W.6
-
25
-
-
0035040596
-
Growth factors in acute myeloid leukemia
-
Estey E.H. Growth factors in acute myeloid leukemia. Best Pract Res: Clin Haematol 2001, 14:175-187.
-
(2001)
Best Pract Res: Clin Haematol
, vol.14
, pp. 175-187
-
-
Estey, E.H.1
-
26
-
-
47549100414
-
Phase 1/2 study of AMG531 in thrombocytopenic patients (pts) with low-risk myelodysplastic syndrome (MDS): update including extended treatment
-
Kantarjian H., Fenaux P., Sekeres M.A., Becker P., Boruchov A., Bowen D., et al. Phase 1/2 study of AMG531 in thrombocytopenic patients (pts) with low-risk myelodysplastic syndrome (MDS): update including extended treatment. Blood 2007, 110:250.
-
(2007)
Blood
, vol.110
, pp. 250
-
-
Kantarjian, H.1
Fenaux, P.2
Sekeres, M.A.3
Becker, P.4
Boruchov, A.5
Bowen, D.6
-
27
-
-
70449726874
-
Effect of the non-peptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndromes
-
Will B., Kawahara M., Luciano J.P., Bruns I., Erickson-Miller C.L., Aivado M.A., et al. Effect of the non-peptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndromes. Blood 2009, 14:3899-3908.
-
(2009)
Blood
, vol.14
, pp. 3899-3908
-
-
Will, B.1
Kawahara, M.2
Luciano, J.P.3
Bruns, I.4
Erickson-Miller, C.L.5
Aivado, M.A.6
|